Antiviral effect of baicalin on Marek's disease virus in CEF cells

19Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Baicalin, the main metabolic component of Scutellaria baicalensis Georgi, has various pharmacological properties including anti-inflammatory, anti-oxidant, anti-apoptotic, anti-bactericidal and anti-viral. The purpose of this study was to investigate the anti-Marek's disease virus (MDV) activities of baicalin in CEF cells. Results: Here, we showed that baicalin could inhibit viral mRNA, protein levels and overall plaque formation in a time-dependent manner. We also found that baicalin could consistently inhibit MDV replication and directly affect the virus infectivity. Moreover, baicalin treatment has no effect on expression level of antiviral cytokine and inflammatory cytokines in MDV infected CEFs. Conclusions: These results demonstrate that baicalin could be a potential drug against MDV infection.

Cite

CITATION STYLE

APA

Yang, F., Feng, C., Yao, Y., Qin, A., Shao, H., & Qian, K. (2020). Antiviral effect of baicalin on Marek’s disease virus in CEF cells. BMC Veterinary Research, 16(1). https://doi.org/10.1186/s12917-020-02595-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free